• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青春期诱导期间及之后的性类固醇替代治疗。

Sex steroid replacement during and after the induction of puberty.

作者信息

Péter Ferenc

机构信息

Buda Children's Hospital, 1023, Budapest, Bolyai-u. 5-7, Hungary.

出版信息

Growth Horm IGF Res. 2003 Aug;13 Suppl A:S136-42. doi: 10.1016/s1096-6374(03)00070-4.

DOI:10.1016/s1096-6374(03)00070-4
PMID:12914742
Abstract

The main aim of sex steroid replacement during induction of puberty is to obtain a balance between healthy psychological and somatic development and optimal final height and peak bone mass (PBM). At present, the age at which it is considered appropriate to begin inducing puberty is younger than it was in the past. This trend aims for optimisation of prepubertal and pubertal growth through earlier onset of growth hormone (GH) therapy and administration of higher doses during puberty as necessary. Adequate initiation of puberty should ensure not only optimal final height and psychological balance, but also normal body proportions, appropriate bone formation and preservation of fertility for children with GH and gonadotropin deficiencies.

摘要

青春期诱导期间进行性类固醇替代的主要目的是在健康的心理和身体发育与最佳最终身高及峰值骨量(PBM)之间取得平衡。目前,开始诱导青春期的适宜年龄比过去更小。这一趋势旨在通过更早开始生长激素(GH)治疗以及在青春期必要时给予更高剂量来优化青春期前和青春期的生长。对于患有GH和促性腺激素缺乏症的儿童,适当启动青春期不仅应确保最佳最终身高和心理平衡,还应保证正常的身体比例、适当的骨形成以及生育能力的保留。

相似文献

1
Sex steroid replacement during and after the induction of puberty.青春期诱导期间及之后的性类固醇替代治疗。
Growth Horm IGF Res. 2003 Aug;13 Suppl A:S136-42. doi: 10.1016/s1096-6374(03)00070-4.
2
Long-term treatment in children with hypopituitarism: pubertal development and final height.儿童垂体功能减退症的长期治疗:青春期发育与最终身高
Horm Res. 1998;49(2):80-5. doi: 10.1159/000023131.
3
Pubertal growth and final height in hypopituitary boys: a minor role of bone age at onset of puberty.垂体功能减退男孩的青春期生长及最终身高:青春期开始时骨龄的作用较小
J Clin Endocrinol Metab. 1986 Aug;63(2):376-82. doi: 10.1210/jcem-63-2-376.
4
Effects of recombinant human growth hormone on height and skeletal maturation in growth hormone-deficient children with and without severe pretreatment bone age delay.
Horm Res. 1999;51(1):15-9. doi: 10.1159/000023307.
5
Sex steroid replacement for induction of puberty in multiple pituitary hormone deficiency.性激素替代疗法用于治疗多种垂体激素缺乏症患者的青春期诱导。
Pediatr Endocrinol Rev. 2009 Jan;6 Suppl 2:298-305.
6
Relative importance of growth hormone and sex steroids for the growth at puberty of trunk length, limb length, and muscle width in growth hormone-deficient children.生长激素缺乏儿童青春期躯干长度、肢体长度和肌肉宽度生长中生长激素和性类固醇的相对重要性。
J Pediatr. 1976 Dec;89(6):1000-8. doi: 10.1016/s0022-3476(76)80620-8.
7
Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.长期接受生长激素治疗的矮小儿童的生长速度、最终身高和骨矿物质代谢
Curr Pharm Biotechnol. 2000 Jul;1(1):33-46. doi: 10.2174/1389201003378997.
8
High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.青春期生长激素缺乏患者高剂量重组人生长激素(GH)治疗可增加最终身高:一项随机、多中心试验。基因泰克公司合作研究组
J Clin Endocrinol Metab. 2000 Oct;85(10):3653-60. doi: 10.1210/jcem.85.10.6906.
9
Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.单独使用生长激素疗法或联合促性腺激素释放激素类似物疗法以改善先天性肾上腺皮质增生症患儿的身高缺陷。
J Clin Endocrinol Metab. 2001 Apr;86(4):1511-7. doi: 10.1210/jcem.86.4.7412.
10
Interrelation of the therapeutic effects of growth hormone and testosterone on growth in hypopituitarism.生长激素与睾酮对垂体功能减退症生长的治疗作用的相互关系。
J Pediatr. 1976 Dec;89(6):992-9. doi: 10.1016/s0022-3476(76)80619-1.